Primer on the Pathogenesis of Severe COVID-19: Part Two
In the following continuation article, the author will expand on how the mechanisms discussed in Part One capitalise on host characteristics to produce the organ specific damage seen in severe coronavirus disease (COVID-19), with specific reference to pulmonary and cardiac manifestations. Pneumonia...
Main Author: | Thomas J. Walsh |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2020-12-01
|
Series: | European Medical Journal |
Subjects: | |
Online Access: | https://www.emjreviews.com/microbiology-infectious-diseases/article/primer-on-the-pathogenesis-of-severe-covid-19-part-two/ |
Similar Items
-
Primer on the Pathogenesis of Severe COVID-19: Part One
by: Thomas J. Walsh
Published: (2020-12-01) -
Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
by: Enrique Ambrocio-Ortiz, et al.
Published: (2021-08-01) -
The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains
by: Rongrong Chen, et al.
Published: (2021-01-01) -
The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19
by: Francesca Silvagno, et al.
Published: (2020-07-01) -
Biochemical parameters and pathogenesis of SARS-CoV-2 infection in vital organs: COVID-19 outbreak in Iran
by: S. Mirmohammadi, et al.
Published: (2020-11-01)